The Schizophrenia Trial of Aripiprazole (STAR), in which patients were. In summary, newer, atypical agents may improve efficacy, patient satisfaction, and aid. Inviato: Gio Ott 04, 2012 10:49 pm Oggetto: | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|